期刊
SCIENCE
卷 322, 期 5898, 页码 77-80出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1161976
关键词
-
资金
- NIH General Medical Sciences [R01 GM078201-01-01]
- Merck
- Amgen
- Bristol-Myers Squibb
- NIH National Service Research Award [F32GM076816]
Photoredox catalysis and organocatalysis represent two powerful fields of molecule activation that have found widespread application in the areas of inorganic and organic chemistry, respectively. We merged these two catalysis fields to solve problems in asymmetric chemical synthesis. Specifically, the enantioselective intermolecular alpha-alkylation of aldehydes has been accomplished using an interwoven activation pathway that combines both the photoredox catalyst Ru(bpy)(3)Cl-2 (where bpy is 2,2 '-bipyridine) and an imidazolidinone organocatalyst. This broadly applicable, yet previously elusive, alkylation reaction is now highly enantioselective and operationally trivial.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据